Detalles de la búsqueda
1.
Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS).
Br J Dermatol
; 189(1): 23-32, 2023 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36999560
2.
A qualitative interview study to explore adolescents' experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures.
Br J Dermatol
; 186(5): 849-860, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34811721
3.
Microsampling in pediatric studies: pharmacokinetic sampling for baricitinib (Olumiant™) in global pediatric studies.
Bioanalysis
; 15(11): 621-636, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37293791
4.
Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol.
Hum Psychopharmacol
; 27(1): 47-56, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22241678
5.
Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients.
Clin Pharmacol Ther
; 104(2): 364-373, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29134648
6.
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
J Clin Invest
; 128(7): 3041-3052, 2018 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29649002
7.
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
Neuropsychobiology
; 56(2-3): 73-85, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18037817
8.
Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
J Psychiatr Res
; 40(4): 337-48, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16271726
9.
Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
J Child Adolesc Psychopharmacol
; 25(4): 293-305, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25978741
10.
A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
J Am Acad Child Adolesc Psychiatry
; 54(4): 283-93, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25791145
11.
Fluoxetine versus placebo in posttraumatic stress disorder.
J Clin Psychiatry
; 63(3): 199-206, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11926718
12.
Pharmacokinetics of orally administered duloxetine in children and adolescents with major depressive disorder.
Clin Pharmacokinet
; 53(8): 731-40, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24989060
13.
A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
J Child Adolesc Psychopharmacol
; 24(4): 170-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24815533
14.
A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
J Child Adolesc Psychopharmacol
; 24(4): 180-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24813026
15.
An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression.
J Child Adolesc Psychopharmacol
; 22(1): 48-55, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22251023
16.
Evaluation of sentinel node biopsy in locally advanced breast cancer patients who become clinically node-negative after neoadjuvant chemotherapy: a preliminary study.
Int J Breast Cancer
; 2011: 870263, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22295236
17.
Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
Int Clin Psychopharmacol
; 26(2): 75-83, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21102344
18.
The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.
J Pain
; 11(2): 109-18, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19665938
19.
Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions.
J Diabetes Complications
; 23(5): 349-59, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-18768332
20.
Early symptom change prediction of remission in depression treatment.
Psychopharmacol Bull
; 42(1): 94-107, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19204654